Low-density lipoprotein stimulates mesangial cell proteoglycan and hyaluronan synthesis.

BACKGROUND Hyperlipidaemia leads to glomerulosclerosis in small mammals and may contribute to progressive renal disease in man. One prominent feature of lipid-induced glomerular injury in animal models is the accumulation of mesangial matrix. These studies were designed to investigate whether low-density lipoprotein (LDL) enhanced mesangial cell (MC) matrix deposition by modulating the production of proteoglycans (PG) and hyaluronan (HA). METHODS Growth arrested human MC were metabolically labelled with either 50 microCi/ml Na(2)[(35)S]sulphate or 25 microCi/ml [(3)H]glucosamine and stimulated with LDL (10-100 microg/ml). The radiolabelled PG and HA extracted from the cell layer and the culture medium were isolated, quantified and characterized. Comparison of the PG core proteins synthesized by MC was carried out using Western blot analysis. RESULTS LDL stimulation led to a dose- and time-dependent increase in [(35)S]sulphate incorporation into PG in the culture medium and to a lesser extent in the cell layer. Analysis of the glycosaminoglycan (GAG) chains showed no difference in either their size or charge. Enzyme digestion studies demonstrated that the synthesis of both chondroitin sulphate PG (CSPG) and heparan sulphate PG (HSPG) was enhanced as was the production of the core proteins of versican (a large CSPG), perlecan (a basement membrane HSPG) and to a lesser extent decorin (a small dermatan sulphate PG (DSPG)). An increase in HA synthesis was also demonstrated in [(3)H]glucosamine labelled cells following LDL stimulation. CONCLUSION LDL selectively enhances the synthesis of specific PG and HA by mesangial cells. Such effects may contribute to the expansion of the mesangial matrix and modify cell-matrix interactions in lipid-induced renal damage.

[1]  M. Daha,et al.  Effects of high glucose on the production of heparan sulfate proteoglycan by mesangial and epithelial cells. , 1996, Kidney international.

[2]  R. Mason,et al.  Rat mesangial cells in vitro synthesize a spectrum of proteoglycan species including those of the basement membrane and interstitium. , 1995, Kidney international.

[3]  R. Mason,et al.  Glomerular mesangial cells in vitro synthesize an aggregating proteoglycan immunologically related to versican. , 1994, The Biochemical journal.

[4]  M. Davies,et al.  The source and possible significance of hyaluronan in the peritoneal cavity. , 1994, Kidney international.

[5]  D. Wheeler,et al.  Oxidation of low density lipoprotein by mesangial cells may promote glomerular injury. , 1994, Kidney international.

[6]  Rosenblum Nd,et al.  The mesangial matrix in the normal and sclerotic glomerulus. , 1994 .

[7]  J. Couchman,et al.  Glomerular matrix: synthesis, turnover and role in mesangial expansion. , 1994, Kidney international.

[8]  A. Yayon,et al.  Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor. , 1994, The Journal of biological chemistry.

[9]  N. Rosenblum The mesangial matrix in the normal and sclerotic glomerulus. , 1994, Kidney international. Supplement.

[10]  P. Vijayagopal Enhanced synthesis and accumulation of proteoglycans in cholesterol-enriched arterial smooth muscle cells. , 1993, The Biochemical journal.

[11]  H. van Goor,et al.  Renal apolipoproteins in nephrotic rats. , 1993, The American journal of pathology.

[12]  B. Kasiske,et al.  Hypertension, hyperlipidemia, and renal damage. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[13]  D. Wheeler,et al.  Interactions between lipoproteins, glomerular cells and matrix. , 1993, Mineral and electrolyte metabolism.

[14]  E. Ruoslahti,et al.  Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease , 1992, Nature.

[15]  N. Kashihara,et al.  Modulation of glomerular proteoglycans by insulin-like growth factor-1. , 1992, Kidney international.

[16]  R. Mason,et al.  Mesangial cell proteoglycans: synthesis and metabolism. , 1992, Journal of the American Society of Nephrology : JASN.

[17]  E. Schönherr,et al.  Effects of platelet-derived growth factor and transforming growth factor-beta 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. , 1991, The Journal of biological chemistry.

[18]  R. Mason,et al.  Characterization of proteoglycans synthesized by human adult glomerular mesangial cells in culture. , 1991, The Biochemical journal.

[19]  R. Mason,et al.  Human glomerular epithelial cell proteoglycans. , 1990, Archives of biochemistry and biophysics.

[20]  S. Srinivasan,et al.  Low-density lipoprotein binding affinity of arterial wall proteoglycans: characteristics of a chondroitin sulfate proteoglycan subfraction. , 1989, Biochimica et biophysica acta.

[21]  S. Klahr,et al.  Progression of renal disease. , 1988, Seminars in nephrology.

[22]  S. Klahr,et al.  The progression of renal disease. , 1989, The New England journal of medicine.

[23]  R. Mason,et al.  Renal glomerular proteoglycans. An investigation of their synthesis in vivo using a technique for fixation in situ. , 1988, The Biochemical journal.

[24]  R W Farndale,et al.  A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. , 1982, Connective tissue research.

[25]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[26]  U. K. Laemmli,et al.  Cleavage of structural proteins during , 1970 .